Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management

Abstract excerpt

Currently, approximately 15,000 to 20,000 patients undergo allogeneic hematopoietic stem cell transplantation (HSCT) annually throughout the world, with the number of long-term survivors increasing rapidly. In long-term follow-up after transplantation, the focus of care moves beyond cure of the original disease to the identification and treatment of late effects after HSCT. One of the more serious complications...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes and associated disorders
• Share to Hematopoietic Stem Cell Transplantation
• Share to Liver Disease Diagnosis and Treatment